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Abstract
Diarrhoeagenic Escherichia coli (DEC) infection is a major health problem in developing countries. The prevalence and characteristics of DEC
have not been thoroughly investigated in China. Consecutive faecal specimens from outpatients with acute diarrhoea in nine sentinel
hospitals in southeastern China were collected from July 2009 to June 2011. Bacterial and viral pathogens were detected by culture and
RT-PCR, respectively. DEC isolates were further classified into five pathotypes using multiplex PCR. The O/H serotypes, sequence types
(STs) and antimicrobial susceptibility profiles of the DEC isolates were determined. A total of 2466 faecal specimens were collected, from
which 347 (14.1%) DEC isolates were isolated. DEC was the dominant bacterial pathogen detected. The DEC isolates included 217 EAEC, 62
ETEC, 52 EPEC, 14 STEC, one EIEC and one EAEC/ETEC. O45 (6.6%) was the predominant serotype. Genotypic analysis revealed that the
major genotype was ST complex 10 (87, 25.6%). Isolates belonging to the serogroups or genotypes of O6, O25, O159, ST48, ST218, ST94
and ST1491 were highly susceptible to the majority of antimicrobials. In contrast, isolates belonging to O45, O15, O1, O169, ST38, ST226,
ST69, ST31, ST93, ST394 and ST648 were highly resistant to the majority of antimicrobials. DEC accounted for the majority of bacterial
pathogens causing acute diarrhoea in southeastern China, and it is therefore necessary to test for all DEC, not only the EHEC O157:H7.
Some serogroups or genotypes of DEC were highly resistant to the majority of antimicrobials. DEC surveillance should be emphasized.
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Diarrhoea caused by Escherichia coli (E. coli) is a major health
problem in developing countries. Diarrhoeagenic E. coli (DEC)
strains are divided into six pathotypes: enteropathogenic E. coli
(EPEC), Shiga toxin-producing (or enterohemorrhagic) E. coli
(STEC), enterotoxigenic E. coli (ETEC), enteroaggregative
E. coli (EAEC), enteroinvasive E. coli (EIEC) and diffusely
adherent E. coli (DAEC) [1,2]. Global epidemics and outbreaks
of all DEC types except DAEC are frequently reported [2].
From May to July of 2011, a large-scale outbreak of DEC
caused 3816 documented infections (including 54 deaths) in
Germany, 845 of which (22%) involved haemolytic uraemic
syndrome (HUS). The outbreak strain was characterized as an
extended-spectrum b-lactamase (ESBL)-expressing E. coli
strain of serotype O104:H4 with virulence factors of both
EHEC and EAEC [3]. China has always been a hotspot of such
epidemics. For example, diarrhoeal epidemics caused by E. coli
O157:H7 were reported in Jiangsu and Anhui provinces in
1999, leading to 20 000 cases of infection and 195 cases of
HUS, with 177 deaths [4]. DEC, the major pathogen causing
diarrhoea [2], is primarily spread by water and food and grows
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in warm, moist places. Although southeastern China has always
been a hotspot for diarrhoea, with potential risks of DEC
epidemics, there is a lack of DEC surveillance data. In this
study, we chose the southeastern region as a representative
region for diarrhoeal epidemics in China to investigate the
epidemiological and aetiological characteristics of DEC.
Materials and Methods
Study design
Nine hospitals, including seven general hospitals, one children’s
hospital and one community hospital, located in different areas
of southeastern China were selected as surveillance sites (Fig.
S1). The subjects were outpatients with acute diarrhoeal
disease (defined as three or more watery or loose stools
during a 24-h period with a duration  14 days). The sentinel
hospitals administered patient questionnaires, collected and
packaged faecal specimens, isolated and identified the bacteria
and stored the isolates. The specimens were frozen at 20°C,
and the isolates were stored at 80°C in trypticase soy broth
(TSB) containing 20% glycerol. The preserved specimens and
isolates were delivered to our laboratory on dry ice for further
identification every 2 weeks. The questionnaires covered
demographic characteristics, illness symptoms, the results of
routine stool tests and medications taken before the visit. The
faecal specimens were collected after informed consent was
obtained from the patients.
Stool culture and phenotypic identification
Two aliquots of each faecal specimen were made immediately
upon arrival at the laboratories of the sentinel hospitals. The
first aliquot was plated on selective media for enteric
pathogens, passaged in enrichment broth and subcultured
after overnight incubation at 35°C. The identities of all isolates
were confirmed using the Vitek-2 Compact bacterial identifi-
cation system (bioMerieux, Marcy l’Etoile, France). The second
aliquot was tested for the presence of viruses. Rotavirus was
detected using a commercial ELISA kit (IDEIATM Rotavirus;
DAKO Ltd, Ely, Cambridgeshire, UK). Calicivirus, astrovirus
and adenovirus were detected using reverse-transcriptase
PCR and real-time PCR. Five lactose-fermenting colonies
suggestive of E. coli were analysed from each MacConkey agar
plate for each subject. DEC isolates were further classified into
five pathotypes by multiplex PCR. The target genes, primer
sequences, PCR conditions, amplification parameters and
interpretation of the results were in accordance with previous
methods described by M€uller et al. [5]. EPEC strain 44155
(escV+, bfpB+), STEC strain EDL933 (stx1+, stx2+ and escV+),
ETEC strain H10407 (elt+, estIa + and estIb+), EIEC strain 44825
(invE+) and EAEC strain O42 (astA+, aggR+ and pic+), which
were kindly provided by the Chinese Center for Disease
Control and Prevention, were used as positive control strains,
and E. coli ATCC25922 was used as a negative control strain
for virulence factor genes.
Serotyping
O and H antigen determination was performed using the tube
agglutination test with specific antisera (50 O antisera and 22
H antisera (Denka Seiken Co. Ltd, Tokyo, Japan) and 14 O
antisera (State Serum Institute, Copenhagen, Denmark))
according to the instructions for the reagents.
Multilocus sequence typing (MLST)
MLST was performed using the Achtman typing scheme (http://
mlst.ucc.ie/mlst/dbs/Ecoli) according to the protocols pub-
lished on the web site. BioNumerics v.6.6 (http://www.
applied-maths.com) was used to generate a minimum spanning
tree from the non-concatenated sequences of seven alleles.
Antimicrobial susceptibility testing and detection of
b-lactamase genes
The isolates were tested for susceptibility to a panel of 18
antimicrobials using the Kirby-Bauer disc-diffusion method.
ESBL-producing isolates were screened using a phenotypic
confirmatory test using cefotaxime, ceftazidime, cefotaxime/
clavulanate and ceftazidime/clavulanate. The results were
interpreted according to the guidelines of the Clinical Labo-
ratory and Standards Institute (CLSI, 2010). Intermediate
susceptibility was analysed as resistance. Multidrug resistance
(MDR) was defined as acquired non-susceptibility to at least
one agent in three or more antimicrobial categories based on
the methods of Magiorakos et al. [6]. The ESBL-positive
isolates were tested by PCR for the presence of blaTEM, blaSHV,
blaCTX-M-1 and blaCTX-M-9 group genes, and amplicons were
sequenced [7]. The DNA sequences were compared with
sequences in GenBank or the b-lactamase classification system
(http://www.lahey.org/studies/) to confirm the subtypes of the
b-lactamase genes. The quality control isolates included E. coli
ATCC25922, Staphylococcus aureus ATCC25923 and Klebsiella
pneumoniae ATCC700603.
Data management and analysis
Demographic and laboratory data were entered into the
information system of the National Infectious Diseases
Surveillance Platform Project. Statistical analyses were per-
formed using SPSS 17.0. The statistical significance of the
differences between the groups was tested by the v2 test or
Fisher’s exact test. All p-values reported were two sided, and
p < 0.05 was considered to be statistically significant.
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Results
Patients
A total of 2466 faecal specimens were collected from nine
sentinel hospitals from July 2009 to June 2011, including 1353
specimens from men and 1113 specimens from women (1.2:1).
Among the patients, 909 (36.9%) were  5 years old, 123
(5.0%) were 6–18 years old, 1200 (48.7%) were 19–60 years
old and 234 (9.5%) were >60 years old.
Prevalence of DEC
The results of the pathogen isolation from the 2466 samples
are shown in Table 1. A total of 347 (14.1%) DEC isolates
were collected, and EAEC (217, 62.5%) was the most prevalent
pathotype identified, followed by ETEC (62, 17.9%), EPEC (52,
15.0%), STEC (14, 4.0%) and EIEC (1, 0.3%). One (0.3%) strain
was astA+, aggR+ and elt+. Among the STEC stains, stx2+ strains
accounted for 78.6%, and none was stx1+ and stx2+ (Table 2).
Serotypes
Among the 347 isolates, 142 (40.9%) were typable for their O
antigens, 6 (1.7%) were defined as ‘rough’, and the O antigen
types of 199 (57.3%) isolates could not be determined. A total
of 35.5% (77/217), 76.7% (43/62), 38.5% (20/52) and 14.3% (2/
14) of EAEC, ETEC, EPEC and STEC isolates were O antigen
typable, respectively. The dominant O serogroups were O45
(23 isolates, 6.6%), O6 (22, 6.3%) and O25 (14, 4.0%), and the
others belonged to 24 serogroups. The EAEC, ETEC and EPEC
isolates belonged to 23, 11 and 9 serogroups, respectively.
O45, O148 and O45 were the predominant serogroups of
EAEC, ETEC and EPEC isolates, respectively. One STEC
isolate was identified as O157:H7 (Table 2).
MLST analysis
A total of 340 isolates (seven isolates died) were analysed and
found to have 166 different sequence types (ST), of which 78
were novel types. The most prevalent genotypes were ST
complex (STC) 10 (87, 25.6%), ST38 (11, 3.2%) and ST226 (10,
2.9%). STC10 includes ST10, ST48, ST218 and 20 other types,
and ST10 is the predominant type among STC10 isolates (25,
28.7%). The EAEC, EPEC and ETEC isolates belonged to 114,
40 and 24 STs, and STC10 accounted for 19.3% (41/212),
21.2% (11/52) and 55.7% (34/61) of isolates, respectively. The
data are presented in Fig. 1(a). A total of 59.1% (13/22) of O6
isolates, 42.9% (6/14) of O25 isolates, 80.0% (8/10) of O148
isolates and 75.0% (6/8) of O159 isolates belonged to ST48,
ST1491, ST94 and ST218, respectively. Two isolates were
EAEC-O104:H4-ST678.
TABLE 1. Frequency of isolated enteric pathogens from
surveillance conducted in southeastern China from July




No. (%) of positive
samples
Diarrhoeagenic Escherichia coli 2466 347 (14.1)
Vibrio parahaemolyticus 2466 184 (7.5)
Plesiomonas shigelloides 2466 64 (2.6)
Aeromonas hydrophila 2466 42 (1.7)
Shigella spp. 2466 30 (1.2)
Vibrio cholerae 2466 19 (0.8)
Salmonella spp. 2466 17 (0.7)
Yersinia enterocolitica 2466 14 (0.6)
Campylobacter spp. 2466 12 (0.5)
Rotavirus a 1900 627 (33.0)
Calicivirus a 1890 384 (20.3)
Astrovirus a 1885 41 (2.2)
Adenovirus a 1899 24 (1.3)
aRotavirus was detected using a commercial ELISA kit. Calicivirus, astrovirus and
adenovirus were detected by reverse-transcriptase PCR and real-time PCR. Virus
detection was performed on part of the specimens only.




isolates Virulence gene (No. of isolates) Serotype (No. of isolates)
EAEC 217 (62.5) astA (161), aggR + pic (14), aggR (13),
astA + pic (11), astA + aggR + pic (8),
astA + aggR (6),pic (4)
O1:HNTa (3), O6:HNT(8), O6:H16(3), O8:HNT(3), O8:H9(1), O15:HNT(8), O18:HNT(1),
O25:HNT(5), O25:H42(1), O28ac:HNT(1), O29:HNT(1), O45:HNT(13), O45:H2(1),
O55:HNT(1), O78:H12(1), O78:HNT(2), O86a:H34(2),O86a:HNT(1), O103:H2(1),
O104:H4(2), O125:H21(2), O126:HNT(1), O127a:H6(1), O128:HNT(1), O148:HNT(1),
O153:H45(1), O153:HNT(2), O159:HNT(1), O166:H27(1), O166:HNT(2), 169:HNT(5),
O rough(6), ONT:HNTb (134)
ETEC 62 (17.9) estIa + estIb (45), elt (12),
elt + estIa + estIb (2), elt + estIb (2),
estIb (1)
O6:HNT(6), O6:H16(5), O15:HNT(1), O25:HNT(4), O25:H42(2), O45:HNT(2), O88:HNT(1),
O91:H21(1), O126:H9(1), O148:H28(8), O148:HNT(1), O153:HNT(1), O159:HNT(6),
O159:H34(1), O169:HNT(3), ONT:HNT(19)
EPEC 52 (15.0) escV (51), escV + bfpB (1) O1:HNT(4), O15:HNT(1), O18:HNT(2), O25:HNT(2), O44:H34(1), O45:HNT(6), O45:H2(1),
O86a:H34(1), O125:H21(1), O153:HNT(1), ONT:HNT(32)
STEC 14 (4.0) stx2 + escV (6), stx2 (5),
stx1 + escV (2), stx1(1)
O1:HNT(1), O157:H7(1), ONT:HNT(12)
EIEC 1 (0.3) invE (1) ONT:HNT(1)
EAEC/ETEC 1 (0.3) astA + aggR + elt (1) ONT:HNT(1)
aHNT = H antigen was non-typable.
bONT:HNT = O and H antigens were non-typable.
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Antimicrobial resistance and ESBL genes
Of the 342 isolates (five isolates died), 91.8% were resistant to
ampicillin; 52.3–57.6% were resistant to cefazolin, tetracycline,
ampicillin-sulbactam and trimethoprim-sulphamethoxazole; and
<10.0% were resistant to piperacillin-tazobactam, cefoxitin and
amikacin. All isolates were sensitive to imipenem and merope-
nem. EAEC, ETEC, EPEC and STEC exhibited different antimi-
crobial resistance patterns (Table 3). The ESBL genotypes were
determined for 104 of the 118 ESBL-positive isolates, and
TEM-type ESBLs were not detected. Nine isolates harboured an
SHV-type ESBL: SHV-12 (4), SHV-5 (2), SHV-2 (2) and SHV-57
(1). The CTX-M ESBLs were detected in 98 isolates. Of these,
33 belonged to the CTX-M-1 group (17 CTX-M-55, 12 CTX-M-
15, 2 CTX-M-3 and 2 CTX-M-22) and 65 belonged to the
(a) (b)
(c)
FIG. 1. Minimum spanning trees of 340 diarrhoeagenic Escherichia coli (DEC) sequence types (STs). The tree is based on the degree of allele sharing by
MLST analysis,with different pathotypes ofDEC (A), positivity and negativity for ESBL(B) and antimicrobial resistance (C). Each circle denotes a particular
ST, and the size of the circle indicates the number of isolates of that particular type. Black lines connecting pairs of STs indicate that they share six (thick
lines), five (thin) or four alleles (dash).Grey dotted lines connecting pairs of STs indicate that they share three toone alleles,with longer lines representing
fewer shared alleles. Only predominant STs ( 7 isolates), ST678 and ST131 aremarked. EAEC, enteroaggregative E. coli; ETEC, enterotoxigenic E. coli;
EPEC, enteropathogenic E. coli; STEC, Shiga toxin-producing E. coli.
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CTX-M-9 group (48 CTX-M-14, 11 CTX-M-65, 3 CTX-M-27, 2
CTX-M-24 and 1 CTX-M-9). Three isolates carried two ESBL
genotypes simultaneously, SHV-12+ CTX-M-65, CTX-M-14+
CTX-M-15 and CTX-M-14+ CTX-M-55.
In the O45, O6 and O25 serogroups, MDR isolates
accounted for 91.3% (21/23), 31.8% (7/22) and 21.4% (3/14)
of isolates, respectively, while ESBL-producing isolates
accounted for 34.8% (8/23), 13.6% (3/22) and 21.4% (3/14),
respectively. In the STC10 group, MDR and ESBL-producing
isolates accounted for 50.6% (44/87) and 19.5% (17/87) of
isolates, respectively. However, 88.0% (22/25) of the ST10
isolates were MDR, whereas only 28.0% (7/25) were ESBL
positive. ST38 (11), ST69 (9), ST31 (8), ST93 (7) and ST648 (7)
isolates were all MDR. A total of 90.1% (10/11) of ST38 isolates
and 85.7% (6/7) of ST648 isolates were ESBL positive, all of
which only carried the CTX-M-14 gene. Isolates belonging to
the serogroups or genotypes of O6, O25, O159, ST48, ST218,
ST94 and ST1491 were highly susceptible to the majority of
antimicrobials. In contrast, isolates belonging to O45, O15, O1,
O169, ST38, ST226, ST69, ST31, ST93, ST394 and ST648 were
highly resistant to the majority of antimicrobials. The relation-
ships between the serogroups or genotypes and antimicrobial
resistance patterns are shown in Figs 1 and 2.
Discussion
The strain causing the 2011 German outbreak belonged to an
EAEC lineage that had enhanced pathogenicity and antimicro-
bial resistance due to the acquisition of genes for Shiga toxin 2
(stx2) and antimicrobial resistance [8]. This outbreak had
serious consequences, emphasizing the importance of detect-
ing all DEC strains, not just EHEC O157:H7 [9]. Our current
study demonstrated that the DEC isolation rate was the
highest among bacterial pathogens. In Europe, Clostridium
TABLE 3. Antimicrobial resistance of diarrhoeagenic Escherichia coli (DEC) isolates from outpatients with acute diarrhoea
Antimicrobiala DEC (n = 342) EAEC† (n = 214) ETEC† (n = 61) EPEC† (n = 52) STEC† (n = 14) pb
AMP 91.8 94.9 86.9 86.5 85.7 0.037
CZO 57.6 63.6 31.1 59.6 71.4 <0.001
TCY 57.0 64.5 27.9 69.2 21.4 <0.001
SAM 55.6 60.7 27.9 67.3 50.0 <0.001
SXT 52.3 59.3 24.6 63.5 21.4 <0.001
CXM 37.1 42.1 14.8 40.4 42.9 <0.001
CTX 35.7 42.1 11.5 36.5 35.7 <0.001
GEN 32.2 36.9 14.8 36.5 21.4 0.008
AMC 26.9 29.4 6.6 32.7 50.0 0.001
CIP 25.4 31.8 6.6 25.0 14.3 0.001
ATM 24.3 27.1 9.8 30.8 14.3 0.020
CAZ 15.5 17.8 6.6 17.3 7.1 0.139
FEP 13.5 16.4 4.9 9.6 14.3 0.106
TZP 7.3 7.9 0.0 15.4 0.0 0.007
FOX 6.4 6.1 0.0 7.7 35.7 <0.001
AMK 3.8 5.1 1.6 1.9 0.0 0.649
IPM 0.0 0.0 0.0 0.0 0.0 NA
MEM 0.0 0.0 0.0 0.0 0.0 NA
ESBL 34.5 40.7 11.5 34.6 35.7 <0.001
MDR 70.2 77.1 34.4 82.7 71.4 <0.001
aAMP, ampicillin; CZO, cefazolin; TCY, tetracycline; SAM, ampicillin-sulbactam; SXT, trimethoprim-sulphamethoxazole; CXM, cefuroxime; CTX, cefotaxime; GEN, gentamicin;
AMC, amoxicillin-clavulanic acid; CIP, ciprofloxacin; ATM, aztreonam; CAZ, ceftazidime; FEP, cefepime; TZP, piperacillin-tazobactam; FOX, cefoxitin; AMK, amikacin; IPM,
imipenem; MEM, meropenem; ESBL, extended-spectrum b-lactamase; MDR, multidrug resistant.
bComparison of the percentages of resistant isolates among the different pathotypes of diarrhoeagenic E. coli; NA, not applicable. Boldface indicates statistical significance
(p < 0.05).
FIG. 2. Heat map of antimicrobial resistance and ESBL genotype
distribution across the predominant diarrhoeagenic Escherichia coli
sequence types (STs) and serogroups. Darker shaded areas indicate a
higher prevalence. AMP, ampicillin; MDR, multidrug resistant; CZO,
cefazolin; SAM, ampicillin-sulbactam; TCY, tetracycline; SXT, trimeth-
oprim-sulphamethoxazole; CXM, cefuroxime; CTX, cefotaxime; ESBL,
extended-spectrum b-lactamase; GEN, gentamicin; AMC, amoxicil-
lin-clavulanic acid; ATM, aztreonam; blaCTX-M, CTX-M b-lactamase
gene; CIP, ciprofloxacin; FEP, cefepime; CAZ, ceftazidime; TZP,
piperacillin-tazobactam; FOX, cefoxitin; AMK, amikacin; IPM, imipe-
nem; MEM, meropenem.
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difficile is considered a frequent cause of community-acquired
diarrhoea [10]. However, in China, stuides on C. difficile are
limited and focus primarily on hospital-acquired diarrhoea
[11]. The prevalence of C. difficile in community-acquired
diarrhoea should be studied further. The DEC isolation rate
was 14.1%, which was higher than the rate of 9.4% reported in
the USA [12] but lower than the rate of 28.6% reported in
South Africa [13]. A report from Brazil showed that economic
status and health conditions were important factors that
influence the prevalence of DEC [14]. The relatively high
EAEC prevalence (62.5%) in this study was higher than that
reported in other regions [12,13,15–18]. The outbreak strain
in Germany harboured an unusual combination of virulence
factors from EAEC and STEC [8]. Interestingly, in our study,
there was one DEC isolate that carried the EAEC virulence
genes astA and aggR as well as the elt gene of ETEC. This result
indicates the possibility that EAEC strains can integrate other
virulence genes to generate outbreak isolates. STEC can
produce Shiga toxin (Stx1 and Stx2), namely verotoxin, which
causes different symptoms and may lead to fatal HUS. The
current study found a lower STEC detection rate, which is
consistent with the results from neighbouring areas such as
Vietnam and Thailand [15,17]. Tarr et al.[19] reported that
Stx2 toxin was more likely to cause HUS. In our study, the
number of STEC isolates carrying stx2 was notably higher than
that carrying stx1.
The true population structure of DEC isolates from the
stool specimens of diarrhoea patients has rarely been studied
using MLST. Previous studies focused primarily on extra-intes-
tinal pathogenic E. coli (ExPEC), especially ExPEC-ST131 [20].
Few studies using MLST have focused on specific pathotypes of
E. coli isolated from stool specimens, such as EAEC or ETEC
[21–23]. Our study was the first to use MLST to determine the
pathogenic characteristics of five pathotypes of DEC. The
results showed that the most common genetic lineage was
STC10 (25.6%). STC10 accounted for 55.7% of ETEC isolates.
Some studies have reported that EAEC in Nigeria belongs to
multiple lineages, among which STC10 accounted for 21.3%
[21]. In our study, the EAEC isolates had 114 STs, and the
most common type was STC10 (19.3%). This result indicates
that the distribution of DEC genotypes differs among regions.
Our current study discovered two EAEC-O104:H4-ST678
isolates that were genetically homologous to the German
outbreak isolates, but the stx2 gene was not found. However,
future surveillance efforts should pay attention to EAEC-O104:
H4-ST678 isolates.
Ampicillin, trimethoprim-sulphamethoxazole and fluoroqu-
inolones are widely used as the first choice to treat intestinal
tract infections because of their ready availability and low cost.
In the current study, the ampicillin resistance rate of DEC was
91.8%, which is higher than the rates of 67.7% in Nicaragua and
62.0% in Iran [24,25]. The ciprofloxacin resistance rate was
much higher than that in Nicaragua and Vietnam [24,26]. This
phenomenon could be explained by the widespread use or
abuse of these antimicrobials in animal husbandry and aqua-
culture in this region of China [27]. In our study, 34.5% of the
DEC isolates were ESBL positive, and the common genotypes
were CTX-M-14, CTX-M-55, CTX-M-15 and CTX-M-65.
CTX-M-14 and CTX-M-15 are widely distributed in
extra-intestinal and intestinal isolates throughout the world.
However, CTX-M-55 and CTX-M-65 were primarily found in
animal intestinal isolates in China [28]. The modes of
transmission of these two CTX-M genes between animals
and humans should be investigated in future work. The
antimicrobial resistance patterns of different serotype/geno-
type isolates were distinct. For ExPEC, Suzuki et al.[29]
reported that O86 isolates were more resistant to sulpha-
methoxazole/trimethoprim, whereas O25 isolates were more
frequently resistant to ceftazidime, cefoxitin, ciprofloxacin and
chloramphenicol. E. coli ST131, a worldwide pandemic clone,
causes predominantly MDR infections and is associated with
O25:H4 and CTX-M-15 [20]. However, the situation was
different in the DEC isolates included in our current study.
Four ST131 isolates, one O25 isolate and three MDR isolates
were negative for the CTX-M genes. In addition, isolates with
the serotypes O6, O25, O159, ST48, ST218, ST94 and ST1491
were highly susceptible to the majority of antimicrobials. In
contrast, isolates with the serotypes O45, O15, O1, O169,
ST38, ST226, ST69, ST31, ST93, ST394 and ST648 were highly
resistant to the majority of antimicrobials. Given these results,
the true relationships between serotypes or genotypes and
antimicrobial resistance patterns were not clear in our study.
A larger number of clinical isolates may be needed to verify the
complex relationships.
In conclusion, DEC accounted for the majority of bacterial
pathogens responsible for acute diarrhoea in southeastern
China, and it is necessary to test for all DEC, not just EHEC
O157:H7. Some serogroups or genotypes of DEC were highly
resistant to the majority of antimicrobials. DEC surveillance
should be emphasized to monitor epidemic trends, reduce
outbreaks and improve the effectiveness of antimicrobial
therapy.
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